Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

DHT, a testosterone byproduct, causes male pattern baldness.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Finasteride exposure affects gene expression and anogenital distance in male rat fetuses.

Finasteride, a hair loss medication, may be linked to stroke in young men.

The treatment combination is effective and generally safe for lung cancer.

Minoxidil, a common hair loss treatment, might work by counteracting a hormone that reduces hair growth and promotes hair loss.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Genes controlling hair growth and immune response are disrupted in male pattern baldness.

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.

AGA causes permanent hair loss; minoxidil helps men, finasteride helps men, minoxidil somewhat helps women, estrogens/antiandrogens lack evidence for women.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Adequate testosterone is crucial for men's health and quality of life, but its decline with age needs more research.

Transit-amplifying cells are crucial for tissue repair and can contribute to cancer when they malfunction.

Suppressing certain hormones might help prevent prostate cancer.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

The article suggests that the view of male baldness as a medical issue is influenced by commercial bias and calls for more unbiased research.

Male faces age with more wrinkles and hair loss, influenced by both body changes and environmental factors.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Some skin patients have body image issues linked to social difficulties but want psychological help.

Consider benefits and risks of new alopecia treatments for safety.

Olive oil compounds may help prevent cancer in animals, but human results are mixed.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.